Neuralink’s 1,024 Threads: Miracle Cure or Work in Progress?
Can Elon Musk’s Neuralink make the paralysed walk and the blind see? We check the viral claim against real patient cases.
By Elke Porter | WBN Ai | v, 2026
Subscription to WBN and being a Writer is FREE!
A claim circulating online says Elon Musk has invented a brain implant of “64 hairs with 16 microbes each” that makes the lame walk and the blind see. The arithmetic is right. Almost everything else is not.
Neuralink’s N1 implant (also called the Link) does use 64 flexible threads, each carrying 16 electrodes, for a total of 1,024 recording sites in the configuration used for the first human patients (and described in the PRIME study materials). Some later implants have been reported with a 128-thread layout (8 electrodes each) that still totals 1,024 sites; more recently, Neuralink has disclosed higher channel counts (around 3,000 in at least one 2026 participant).
They are not microbes, and they are not hairs. They are ultra-fine polymer threads (polyimide with thin metal conductors), thinner than a human hair—typically described as roughly one-tenth the thickness or in the range of a few to tens of micrometers wide and only a few micrometers thick. A surgical robot (the R1) inserts them into the motor cortex, the region that plans voluntary movement. The threads are deliberately designed to be too fine and flexible for reliable manual placement by a human surgeon.
The device does not heal damaged nerves, repair spinal cord injuries, or restore natural limb movement or vision. It is a brain-computer interface that records the electrical spikes of neurons associated with a person’s intention to move (or, in other trial arms, to speak). Onboard electronics amplify, digitize, and process those signals; the implant then wirelessly transmits the data (via Bluetooth) to a phone, computer, or other external device, where decoding software turns the patterns into cursor movement, clicks, typing, or commands for a robotic arm.
What participants can actually do
As of 2026, Neuralink’s human trials (PRIME and related studies in the US, Canada, UK, and elsewhere) have enrolled dozens of participants with severe paralysis from spinal cord injury, ALS, or similar conditions. Documented capabilities include:
- Controlling a computer cursor and phone at speeds that can match or exceed typical able-bodied mouse use (one reported peak of 11.32 bits per second).
- Browsing the web, playing games, using design software, creating digital art, and typing by imagined movements.
- Operating assistive robotic arms for tasks such as grasping objects or feeding.
- In the separate VOICE trial, decoding intended speech into synthesized voice for people with severe speech impairment.
None of this restores the ability to walk. Control remains external—digital devices or robotic systems—rather than reanimation of the user’s own limbs.
Vision and “making the blind see”
The claim that the implant makes the blind see is also incorrect for the current N1 motor device. Neuralink is developing a separate visual prosthesis called Blindsight, which aims to stimulate the visual cortex directly (bypassing the eyes and optic nerve) using camera input to generate phosphenes (points of light). It received FDA Breakthrough Device Designation in 2024. As of mid-to-late 2026, public evidence of successful human vision restoration with Blindsight remains limited or absent in verified reports; much of the work is still preclinical or early-stage.
Other important context
The first participant (Noland Arbaugh, implanted January 2024) experienced substantial thread retraction—reports estimated ~85% of threads pulled back from cortical tissue—reducing the number of usable electrodes. Software adjustments restored useful performance, and subsequent surgical techniques were refined. The implant sits flush in the skull, is wirelessly charged, and has no external wires once healing is complete. It remains an investigational device available only through clinical trials; it is not commercially approved.
In short: the “64 × 16 = 1,024” figure matches Neuralink’s early human N1 design, but the rest of the viral claim—microbes, healing nerves, restoring walking, or restoring sight with that device—is false or premature. The technology is a high-channel recording BCI that translates motor (and speech) intentions into digital or robotic commands for people with severe paralysis.
Could it be used against us?
A device that reads the brain raises questions no smartphone ever has. Who owns your neural data? Could an implant be hacked? What happens to patients if a company folds? That last risk is not theoretical: blind users of Second Sight’s retinal implants were left without support when that firm ran into trouble. Musk himself has framed the goal as going beyond medicine, saying the technology could enable symbiosis between the human brain and artificial intelligence. mobihealthnews
For now, Neuralink is a remarkable assistive tool for a small number of people. It is not a cure, and the safeguards for what comes next still need to be written.
Elke Porter at:
Westcoast German Media
LinkedIn: Elke Porter or
WhatsApp: +1 604 828 8788.
Public Relations. Communications. Education
Let’s bring your story to life — contact me for books, articles, blogs, and bold public relations ideas that make an impact.
TAGS: #Neuralink #ElonMusk #BrainComputerInterface #Neurotech #FactCheck #HealthTech
Members Discussion